Back to News
Market Impact: 0.6

Buffett's Big Finish? Berkshire Hathaway strikes $9.7bn deal for OxyChem

BRK.AOXY
M&A & RestructuringCompany FundamentalsCorporate EarningsManagement & GovernanceCommodities & Raw Materials
Buffett's Big Finish? Berkshire Hathaway strikes $9.7bn deal for OxyChem

Berkshire Hathaway is acquiring Occidental Petroleum's OxyChem unit for $9.7 billion in cash, marking Warren Buffett's largest deal in years and deploying a significant portion of Berkshire's $344 billion cash pile into an industrial asset. For Occidental, this sale is crucial for debt reduction following its CrownRock acquisition, a move positively received by the market with OXY shares up 0.8% pre-market. The transaction highlights Berkshire's strategic capital deployment and Occidental's deleveraging focus.

Analysis

Berkshire Hathaway's $9.7 billion all-cash acquisition of OxyChem from Occidental Petroleum marks a significant capital deployment and a strategic expansion of its industrial portfolio. The deal utilizes a portion of Berkshire's idle $344 billion cash pile and echoes its 2011 purchase of chemical group Lubrizol, indicating a consistent strategy of acquiring profitable, foundational businesses. OxyChem’s reported pre-tax earnings of $213 million last quarter suggest it will be an accretive asset. For Occidental Petroleum, the divestiture is a critical step in its deleveraging plan following the CrownRock acquisition, adding to $4 billion in other recent asset sales. The positive market reaction, with OXY's stock climbing 0.8% pre-market, underscores investor approval of the move to strengthen its balance sheet.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo